• Results
  • Key finding: Access planning: Eight companies adopt processes to systematic...
Key finding: Access planning

Eight companies adopt processes to systematically address access to medicine for all new products

Making new medicines rapidly available to patients who need them, requires tactical planning throughout the development phase. The 2021 Index finds that eight companies are leading the way in their approach to planning ahead for access. 

Explore further

How we measure

How we measure

The Index evaluates pharmaceutical companies in areas where they have the biggest potential and responsibility to make change, such as R&D and pricing. Find out more about the analytical framework and areas of evaluation.

Get in touch

Back to top |